[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape

December 2022 | 153 pages | ID: G15FDC6D41ABEN
Prodture

US$ 2,299.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global generic injectable market is expected to grow at a CAGR of around 7.8% during 2023-2030. This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region. Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
      • Government Taking Initiatives to Support Manufacture in Various Countries
  • Aging Population and Rising Prevalence of Chronic Diseases
  • Cheaper and Shorter R&D
Market Challenges
  • Contamination Concerns for Injectable Manufactured in Factories in Some Countries
Historical & Forecast Period

Base Year: 2022

Historical Period: 2018-2022

Forecast Period: 2023-2030

Market by Therapeutic Area
  • Oncology
  • Anaesthesia
  • Anti-infective
  • Parenteral Nutrition
  • Cardiovascular Diseases
Market by Containers
  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
Market by Distribution Channel
  • Hospitals
  • Retail Pharmacy
Market by Region
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Rest of Europe
  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • Rest of Middle East & Africa
1. PREFACE

1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
  1.4.1 Phase I
  1.4.2 Phase II
  1.4.3 Phase III
1.5 Assumptions

2. KEY INSIGHTS

3. GLOBAL GENERIC INJECTABLE MARKET

3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. GLOBAL GENERIC INJECTABLE MARKET ANALYSIS

4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. GLOBAL GENERIC INJECTABLE MARKET BY THERAPEUTIC AREA

5.1. Introduction
5.2. Oncology
5.3. Anaesthesia
5.4. Anti-infective
5.5. Parenteral Nutrition
5.6. Cardiovascular Diseases

6. GLOBAL GENERIC INJECTABLE MARKET BY CONTAINERS

6.1. Introduction
6.2. Vials
6.3. Ampoules
6.4. Premix
6.5. Prefilled Syringes

7. GLOBAL GENERIC INJECTABLE MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction
7.2. Hospitals
7.3. Retail Pharmacy

8. GLOBAL GENERIC INJECTABLE MARKET BY REGION

8.1 Introduction
8.2 Europe
  8.2.1 Germany
  8.2.2 United Kingdom
  8.2.3 France
  8.2.4 Italy
  8.2.5 Spain
  8.2.6 Russia
  8.2.7 Netherlands
  8.2.8 Rest of the Europe
8.3 North America
  8.3.1 United States
  8.3.2 Canada
8.4 Asia Pacific
  8.4.1 China
  8.4.2 Japan
  8.4.3 India
  8.4.4 South Korea
  8.4.5 Australia
  8.4.6 Indonesia
  8.4.7 Rest of the Asia Pacific
8.5 Latin America
  8.5.1 Mexico
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Rest of Latin America
8.6 Middle East & Africa
  8.6.1 Saudi Arabia
  8.6.2 Turkey
  8.6.3 Iran
  8.6.4 Rest of Middle East & Africa

9. SWOT ANALYSIS

10. PORTER’S FIVE FORCES

11. MARKET VALUE CHAIN ANALYSIS

12. COMPETITIVE LANDSCAPE

12.1 Competitive Scenario
12.2 Company Profiles
  12.2.1 Hospira (Pfizer)
  12.2.2 Fresenius Kabi
  12.2.3 Hikma Pharma PLC
  12.2.4 Sandoz (Novartis)
  12.2.5 Sagent Inc.
  12.2.6 Sanofi
  12.2.7 Baxter
  12.2.8 Dr. Reddy Laboratories
  12.2.9 Akorn Inc.
  12.2.10 Fresenius SE & Co. KGaA
  12.2.11 Mylan N.V.
  12.2.12 Teva Pharmaceutical Industries Ltd
  12.2.13 Lupin Ltd
  12.2.14 Aurobindo Pharma
  12.2.15 Biocon


LIST OF TABLES

Table 1: Global Generic Injectable Market Portraiture
Table 2: Global Generic Injectable Market by Therapeutic Area (in US$ Million), 2022 & 2030
Table 3: Global Generic Injectable Market by Containers (in US$ Million), 2022 & 2030
Table 4: Global Generic Injectable Market by Distribution Channel (in US$ Million), 2022 & 2030
Table 5: Global Generic Injectable Market by Region (in US$ Million), 2022 & 2030
Table 6: Europe Generic Injectable Market by Country (in US$ Million), 2022 & 2030
Table 7: North America Generic Injectable Market by Country (in US$ Million), 2022 & 2030
Table 8: Asia Pacific Generic Injectable Market by Country (in US$ Million), 2022 & 2030
Table 9: Latin America Generic Injectable Market by Country (in US$ Million), 2022 & 2030
Table 10: Middle East & Africa Generic Injectable Market by Country (in US$ Million), 2022 & 2030
Table 11: List of Key Players

LIST OF FIGURES

Figure 1: Global Generic Injectable Market (in US$ Million), 2018-2022
Figure 2: Global Generic Injectable Market by Therapeutic Area, 2022
Figure 3: Global Generic Injectable Market by Containers, 2022
Figure 4: Global Generic Injectable Market by Distribution Channel, 2022
Figure 5: Global Generic Injectable Market by Region, 2022
Figure 6: Global Generic Injectable Market (in US$ Million), 2023-2030
Figure 7: Global Generic Injectable Market by Therapeutic Area (in %), 2022 & 2030
Figure 8: Global Oncology Generic Injectable Market (in US$ Million), 2018-2022
Figure 9: Global Oncology Generic Injectable Market (in US$ Million), 2023-2030
Figure 10: Global Anaesthesia Generic Injectable Market (in US$ Million), 2018-2022
Figure 11: Global Anaesthesia Generic Injectable Market (in US$ Million), 2023-2030
Figure 12: Global Anti-infective Generic Injectable Market (in US$ Million), 2018-2022
Figure 13: Global Anti-infective Generic Injectable Market (in US$ Million), 2023-2030
Figure 14: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2018-2022
Figure 15: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2023-2030
Figure 16: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2018-2022
Figure 17: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2023-2030
Figure 18: Global Generic Injectable Market by Containers (in %), 2022 & 2030
Figure 19: Global Vials Generic Injectable Market (in US$ Million), 2018-2022
Figure 20: Global Vials Generic Injectable Market (in US$ Million), 2023-2030
Figure 21: Global Ampoules Generic Injectable Market (in US$ Million), 2018-2022
Figure 22: Global Ampoules Generic Injectable Market (in US$ Million), 2023-2030
Figure 23: Global Premix Generic Injectable Market (in US$ Million), 2018-2022
Figure 24: Global Premix Generic Injectable Market (in US$ Million), 2023-2030
Figure 25: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2018-2022
Figure 26: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2023-2030
Figure 27: Global Generic Injectable Market by Distribution Channel (in %), 2022 & 2030
Figure 28: Global Hospitals Generic Injectable Market (in US$ Million), 2018-2022
Figure 29: Global Hospitals Generic Injectable Market (in US$ Million), 2023-2030
Figure 30: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2018-2022
Figure 31: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2023-2030
Figure 32: Global Generic Injectable Market by Region (in %), 2022 & 2030
Figure 33: Europe Generic Injectable Market (in US$ Million), 2018-2022
Figure 34: Europe Generic Injectable Market (in US$ Million), 2023-2030
Figure 35: Europe Generic Injectable Market by Country (in %), 2022 & 2030
Figure 36: Germany Generic Injectable Market (in US$ Million), 2018-2030
Figure 37: United Kingdom Generic Injectable Market (in US$ Million), 2018-2030
Figure 38: France Generic Injectable Market (in US$ Million), 2018-2030
Figure 39: Italy Generic Injectable Market (in US$ Million), 2018-2030
Figure 40: Spain Generic Injectable Market (in US$ Million), 2018-2030
Figure 41: Russia Generic Injectable Market (in US$ Million), 2018-2030
Figure 42: Netherlands Generic Injectable Market (in US$ Million), 2018-2030
Figure 43: North America Generic Injectable Market (in US$ Million), 2018-2022
Figure 44: North America Generic Injectable Market (in US$ Million), 2023-2030
Figure 45: North America Generic Injectable Market by Country (in %), 2022 & 2030
Figure 46: United States Generic Injectable Market (in US$ Million), 2018-2030
Figure 47: Canada Generic Injectable Market (in US$ Million), 2018-2030
Figure 48: Asia Pacific Generic Injectable Market (in US$ Million), 2018-2022
Figure 49: Asia Pacific Generic Injectable Market (in US$ Million), 2023-2030
Figure 50: Asia Pacific Generic Injectable Market by Country (in %), 2022 & 2030
Figure 51: China Generic Injectable Market (in US$ Million), 2018-2030
Figure 52: Japan Generic Injectable Market (in US$ Million), 2018-2030
Figure 53: India Generic Injectable Market (in US$ Million), 2018-2030
Figure 54: South Korea Generic Injectable Market (in US$ Million), 2018-2030
Figure 55: Australia Generic Injectable Market (in US$ Million), 2018-2030
Figure 56: Indonesia Generic Injectable Market (in US$ Million), 2018-2030
Figure 57: Latin America Generic Injectable Market (in US$ Million), 2018-2022
Figure 58: Latin America Generic Injectable Market (in US$ Million), 2023-2030
Figure 59: Latin America Generic Injectable Market by Country (in %), 2022 & 2030
Figure 60: Mexico Generic Injectable Market (in US$ Million), 2018-2030
Figure 61: Brazil Generic Injectable Market (in US$ Million), 2018-2030
Figure 62: Argentina Generic Injectable Market (in US$ Million), 2018-2030
Figure 63: Middle East & Africa Generic Injectable Market (in US$ Million), 2018-2022
Figure 64: Middle East & Africa Generic Injectable Market (in US$ Million), 2023-2030
Figure 65: Middle East & Africa Generic Injectable Market by Country (in %), 2022 & 2030
Figure 66: Saudi Arabia Generic Injectable Market (in US$ Million), 2018-2030
Figure 67: Turkey Generic Injectable Market (in US$ Million), 2018-2030
Figure 68: Iran Generic Injectable Market (in US$ Million), 2018-2030
Figure 69: Market Value Chain

More Publications

Need Help?

Ask a Question

Market Reports

All Categories